Advertisement
UK markets closed
  • NIKKEI 225

    37,552.16
    +113.55 (+0.30%)
     
  • HANG SENG

    16,828.93
    +317.24 (+1.92%)
     
  • CRUDE OIL

    83.37
    +1.47 (+1.79%)
     
  • GOLD FUTURES

    2,337.30
    -9.10 (-0.39%)
     
  • DOW

    38,476.70
    +236.72 (+0.62%)
     
  • Bitcoin GBP

    53,486.54
    +224.72 (+0.42%)
     
  • CMC Crypto 200

    1,435.22
    +20.46 (+1.45%)
     
  • NASDAQ Composite

    15,706.15
    +254.84 (+1.65%)
     
  • UK FTSE All Share

    4,378.75
    +16.15 (+0.37%)
     

BUZZ-U.S. Stocks on the Move-Kamada, Mitek, Stereotaxis, Shoe Carnival

(For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for more market insights, including options activity, ; for the Day Ahead newsletter, http://link.reuters.com/mex49s; for the Morning News Call newsletter, http://link.reuters.com/nex49s)

U.S. stocks opened slightly higher on Thursday, after the European Central Bank cut interest rates to record lows and a flurry of economic data indicated the U.S. economy was steadily improving. The Dow Jones industrial average was up 0.37 percent at 17,141.44, the S&P 500 was up 0.40 percent at 2,008.66 and the Nasdaq Composite was up 0.2 percent 4,581.71.

** SHOE CARNIVAL INC (NasdaqGS: SCVL - news) , $19.635, -11.39 pct

The footwear retailer reported lower-than-expected second quarter sales and profit as fewer customers visited its stores and expenses rose. Its profit has now missed estimates for the last three quarters. The company forecast third quarter comparable-store sales to either decline up to 1 percent or grow up to 1 percent.

ADVERTISEMENT

Susquehanna Financial Group analysts cut price target to $24 from $25 on the stock which had fallen 24 percent this year up to Wednesday's close.

** SOLARCITY CORP, $71.3, +5.29 pct

The solar panel installer said it would open 20 new operations centres in seven U.S. states. The company, backed by Tesla Motors Inc (Xetra: A1CX3T - news) founder Elon Musk, says new centers expected to create more than 600 additional jobs.

** BAZAARVOICE INC (NasdaqGS: BV - news) , $8.09, +7.87 pct

B. Riley & Co raises price target on stock of the software maker to $10 from $9.75, saying net new client additions in Q1 were significantly higher than it had estimated.

Bazaarvoice, which provides businesses online and social media tools to interact with customers, reported higher-than-expected Q1 revenue and smaller-than-expected loss on Wednesday

** VERIFONE SYSTEMS INC (NYSE: PAY - news) , $35.93, +4.02 pct

The credit card swipe machine maker raised full-year revenue forecast for the third time, encouraged by strong sales of devices that can accept chip-embedded credit cards. VeriFone also raised full-year profit forecast and reported better-than-expected third quarter revenue.

The company is benefiting as U.S. retailers upgrade their point-of-sale terminals to systems compatible with more secure credit cards in the wake of several data breaches. Up to Wednesday's close, the stock had risen nearly 30 percent this year.

** ARLINGTON ASSET INVESTMENT CORP, $27.14, -4.40 pct

The mortgage investor said it was offering 2.75 million shares of Class A common stock - 14 percent of its total outstanding shares - at $27.61 each, a 2.7 pct discount to Wednesday's close.

Arlington said it plans to use the proceeds to acquire assets. Up to Wednesday's close, the stock had risen 7.6 percent this year.

** STEREOTAXIS INC (NasdaqCM: STXS - news) ,$3.31, +16.14 pct

The medical device maker received U.S. FDA's marketing approval for its device used during procedures to assess heart activity. The device, called Vdrive Robotic Navigation System, is designed to remotely control catheter during such procedures.

** KAMADA LTD (NasdaqGS: KMDA - news) , $5.6, -21.79 pct

The Israel-based drugmaker's experimental drug to treat an inherited condition that raises the risk of lung and liver disease failed in a mid-stage study. The drug, Inhaled Alpha-1 Antitrypsin, did not show a statistically significant difference, compared with a placebo. Glassia, an intravenous version of the drug, is already being marketed by Baxter Inc in the United States.

** CIENA CORP, $19.13, -6.50 pct

The network equipment forecast fourth quarter revenue of $570 million-$610 million, below the average analyst estimate of $628.9 million. The company said it expects fourth quarter adjusted gross margin in the high 30s to low 40s percent range.

** MITEK SYSTEMS INC (NasdaqCM: MITK - news) , $3.46, +45.99 pct

The mobile imaging software maker agreed on Wednesday to settle all pending litigation with financial services group USAA over five of its patents relating to image capture on mobile devices. Mitek's lawsuit filed in 2012 also included allegations of misappropriation of trade secrets, breach of contract and fraud. The company said neither party will make any payment or admit liability on any claims.

** GOPRO INC (Xetra: A1XE7G - news) , $54.865, -3.51 pct

J.P. Morgan cut its rating on the stock of the maker of camera makers to "neutral" from "overweight", saying the stock is trading above its price target of $51. The median price target on stock is $46.50. Of nine analysts covering the stock, 2 have "buy" ratings and 7 have "hold" or equivalent ratings. Up to Wednesday's close, the stock had risen 137 percent since its debut on June 26.

** MEMORIAL PRODUCTION PARTNERS LP (NasdaqGS: MEMP - news) , $22.28, -3.80 pct

The oil and gas producer said it would offer 13 million common units; representing 18 percent of outstanding shares as of Wednesday. The company said it plans to use net proceeds from the underwritten public offering to pay down debt.

** MATTRESS FIRM HOLDING CORP, $63.443, +11.68 pct

The company said it would buy privately held bedding retailer The Sleep Train Inc for $425 million, its sixth and largest acquisition announced in the past year, to expand its presence on the West Coast.

** NEWLINK GENETICS CORP, $26.73, +2.93 pct

NewLink Genetics said the U.S. Food and Drug Administration allowed the company to start testing an experimental Ebola vaccine in humans.

The move follows a decision to begin initial human testing of a GlaxoSmithKline (Other OTC: GLAXF - news) vaccine this month and an approval to fast track tests of a Johnson & Johnson (NYSE: JNJ - news) vaccine.

** TIBCO SOFTWARE INC (NasdaqGS: TIBX - news) , $22, +4.56 pct

The business software maker said it was reviewing its strategic and financial alternatives as part of a process initiated by its board on Aug. 16 to maximize shareholder value. The company has formed a special committee of independent directors to undertake the review.

** MATRIX SERVICE CO, $22.29, -23.48 pct

The engineering and construction services provider's fourth quarter revenue and profit missed analysts' estimates due to a 47 percent rise in costs. Revenue from the company's oil, gas and chemical segment, which provides construction and maintenance services to North American oil producers, fell about 22 percent to $52.1 million. Matrix also forecast full-year earnings below estimates.

** PVH CORP (NYSE: PVH - news) , $127.74, +9.06 pct

The apparel company's second quarter profit beat expectations, helped by strong sales of its Tommy Hilfiger-branded clothes. PVH cut its full-year revenue forecast to $8.4 billion from $8.5 billion, but it reaffirmed its profit forecast.

** JOY GLOBAL INC (NYSE: JOY - news) , $61.56, -1.03 pct

The mining equipment maker posted lower-than-expected quarterly revenue and profit and the company narrowed its full-year earnings forecast range as coal miners cut spending due to weak coal prices amid an oversupply. (Compiled by Rohit T.K. in Bangalore; Editing by Joyjeet Das)